Glaucoma management update: what's really important to you and your patients?
A group of glaucoma experts updated their peerson the latest findings from clinical trials for glaucoma diagnosis and progressionthat can be applied in clinical practice during a CME program Sunday eveningat the Marriott Anaheim. Under the leadership of Robert N. Weinreb, MD,of the University of California at San Diego, panelists also discussed structuraland functional measures for detecting the progression of glaucoma and variousaspects of glaucoma surgery.
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.